Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma.
Journal: Journal for immunotherapy of cancer
Published: March 04, 2024
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Journal: British journal of haematology
Published: March 15, 2023
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 07, 2023
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.
Journal: American journal of respiratory and critical care medicine
Published: September 13, 2022
Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 22, 2020
Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: July 26, 2019
Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation.
Journal: Journal of cardiac failure
Published: January 26, 2017
Last Updated: 09/26/2026